ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2025

Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome

Francesca Ricci1, Antonella Meini1, Lucio Verdoni2, Laura Dotta1, Marta Bolis2, Marco Berlucchi3, Gianfranco Savoldi4 and Marco Cattalini2, 1Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 2Pediatric Clinic, Spedali Civili di Brescia and University of Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 3Spedali Civili di Brescia, Department of Pediatric Otorhinolaryngology, Brescia, Italy, 4Spedali Civili di Brescia, Angelo Nocivelli Institute of Molecular Medicine, Brescia, Italy

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Diagnostic criteria, Fever, pediatric rheumatology and steroids

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et al. It is characterized by regular recurrence of fever which associates with aphthous lesions,  pharyngitis and cervical adenitis. In 1999 the criteria for diagnosis of PFAPA were formulated by Thomas. PFAPA is considered peculiar to the pediatric age, but in the recent literature there are a few case reports of this syndrome in adults

Methods: We reviewed medical records of 239 children meeting clinical criteria for PFAPA syndrome

Results:

in our cohort (136 males and 103 females) fever began at a mean of 2.1 ±2 years of age. The majority of the children had a symptoms onset before the fifth year of life but 9% of the patients had a later onset. Since all the other clinical criteria but age were met in these latter patients, the diagnosis of PFAPA was confirmed. In 37% of the patients’ family history there was at least one first- or second-degree relative who underwent tonsillectomy for recurrent fevers or suffered from recurrent fevers in childhood. The PFAPA episodes lasted a mean of 4±2 days, with an interval between episodes of 28.3 days. Fever was accompanied by pharyngitis (98%),  cervical adenitis (64%),  aphthous stomatitis (39%) and  abdominal pain (33%). The parents reported in 10% of their children that some symptoms (irritability, nausea, headache) appeared 24-48 hours before fever onset and the parents learned to interpret these symptoms as prodromes of the PFAPA attack. All the patients were treated with oral steroids, using a single somministration of 1mg/kg of prednisone equivalent the first day of fever. All the patients had a prompt response to steroid treatment and only 12% of the patients experience a free-interval shortening.

In 57% of our patients the disease resolved spontaneously, after a mean period of 3 years. Medium age at PFAPA resolution was 5,7 ±3 years of age.

Among patients who underwent tonsillectomy (25%) only a single patient didn’t have complete resolution. Mutation analysis for FMF, HIDS and TRAPS in this patient was negative.

When clustering our population for age at onset (less than 1 yr, 1-5 years, more than 5 years) we observed that patients with onset within the first year had a significantly longer duration of disease (p<0.00002).

Conclusion: our study indicates that the 5 years of age cut-off is too strict for considering PFAPA diagnosis and that the onset before the first year of life predicts a longer disease duration. As previously reported abdominal pain are a relevant feature in PFAPA, almost as common as aphtous stomatitis. We also observed “prodromic symptoms” quite commonly. A significant proportion of  family histories is indicative of possible PFAPA Syndrome in the first or second degree relatives of our patients. In our experience prednisone in a single given dose is highly efficacious in managing patients with PFAPA, and the free interval reduction happens in a minority of patients. Finally, even though limited to few patients, tonsillectomy had a very high rate of success in our experience, probably due to very strict selection of patients undergoing tonsillectomy.


Disclosure:

F. Ricci,
None;

A. Meini,
None;

L. Verdoni,
None;

L. Dotta,
None;

M. Bolis,
None;

M. Berlucchi,
None;

G. Savoldi,
None;

M. Cattalini,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2012

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-therapy-response-in-a-large-single-centre-cohort-of-patients-with-periodic-fever-with-aphtous-stomatitis-pharyngitis-and-cervical-adenitis-syndrome/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology